Showing results (31-40 of 100) with videos related to

Sort By:
Pageof 10
European Heart Journal|November 16, 2004
Troponin is more useful than creatine kinase in predicting one-year mortality among acute coronary syndrome patientsAndrew T Yan, Raymond T Yan, Mary Tan, et al.
The Journal of Invasive Cardiology|April 10, 2008
B-type natriuretic peptide and serum unbound free fatty acid levels after contemporary percutaneous coronary interventionWarren J Cantor, Hahn Hoe Kim, Sanjit Jolly, et al.
Cardiovascular Diabetology|July 11, 2024
Effect of empagliflozin on total myocardial infarction events by type and additional coronary outcomes: insights from the randomized EMPA-REG OUTCOME trialDavid Fitchett, Bernard Zinman, Silvio E Inzucchi, et al.
Diabetes, Obesity & Metabolism|December 3, 2019
Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?Silvio E Inzucchi, David Fitchett, Dubravka Jurišić-Eržen, et al.
American Heart Journal|October 18, 2008
Clinical implications of a next-day follow-up electrocardiogram in patients with non-ST elevation acute coronary syndromesSalem Alkaabi, Fahad Baslaib, Amparo Casanova, et al.
Archives of Internal Medicine|February 13, 2008
Use of cardiac catheterization for non-ST-segment elevation acute coronary syndromes according to initial risk: reasons why physicians choose not to refer their patientsCindy H Lee, Mary Tan, Andrew T Yan, et al.
Lancet (London, England)|July 23, 2013
Effect of calcium-based versus non-calcium-based phosphate binders on mortality in patients with chronic kidney disease: an updated systematic review and meta-analysisSophie A Jamal, Ben Vandermeer, Paolo Raggi, et al.
Journal of Diabetes and Its Complications|August 26, 2023
Changes in cardiac and vascular haemodynamics as potential mediators of improvements in cardiovascular and kidney outcomes with empagliflozin in type 2 diabetesBernhard K Krämer, Sibylle J Hauske, Robert Chilton, et al.
Diabetes Research and Clinical Practice|May 22, 2024
Impact of empagliflozin on first and recurrent events leading to or prolonging hospitalisation in the EMPA-REG OUTCOME trialSilvio E Inzucchi, Christoph Wanner, David Fitchett, et al.
The American Journal of Cardiology|August 9, 2006
Prognostic significance of admission heart failure in patients with non-ST-elevation acute coronary syndromes (from the Canadian Acute Coronary Syndrome Registries)Amit Segev, Bradley H Strauss, Mary Tan, et al.
Pageof 10